Uncategorized

Win the Patent War Before the Drug Goes Generic: How Paragraph IV Challenges and Pay-for-Delay Settlements Decide Who Gets Paid — and Who Gets Blocked

Generic entry isn’t just a legal milestone—it’s a financial event that decides who gets paid, who gets blocked, and how quickly patients get access.
Here’s the part most people miss: the “patent war” doesn’t begin when a drug goes generic. It begins be…

Win the Patent War Before the Drug Goes Generic: How Paragraph IV Challenges and Pay-for-Delay Settlements Decide Who Gets Paid — and Who Gets Blocked Read Post »

Biotechblog
Scroll to Top